Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Haemodynamic response

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    28 result(s) found for: Haemodynamic response. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2006-006981-40 Sponsor Protocol Number: hypertension2006-006981-40 Start Date*: 2007-05-03
    Sponsor Name:Cambridge University Hospitals NHS Foundation Trust jointly with University of Cambridge
    Full Title: Does the underlying haemodynamic abnormality determine response to antihypertensive therapy in patients with hypertension?
    Medical condition: Essential hypertension
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004254 Benign essential hypertension LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) EE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005476-32 Sponsor Protocol Number: VR004/008 Start Date*: 2006-02-02
    Sponsor Name:Vectura Group plc
    Full Title: A Phase IIb, Randomised, Double-Blind, Placebo Controlled, Dose Finding Study Assessing the Haemodynamic Safety and "At Home" Efficacy of Inhaled VR004 in patients with Erectile Dysfunction (ED).
    Medical condition: Erectile dysfunction
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-019591-67 Sponsor Protocol Number: 1008032 Start Date*: 2010-06-01
    Sponsor Name:CHU de SAINT-ETIENNE
    Full Title: Pain assessment during general anesthesia : DOLANS Study
    Medical condition: perioperative analgesia
    Disease: Version SOC Term Classification Code Term Level
    12.1 10054799 Perioperative analgesia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002875-25 Sponsor Protocol Number: NEO-CIRC-003 Start Date*: 2018-07-24
    Sponsor Name:SERMAS-FIBHULP
    Full Title: An international multicentre randomized placebo-controlled, double blind three arm trial to investigate the efficacy of dobutamine with two different starting doses in the treatment of haemodynamic...
    Medical condition: Haemodynamic insufficiency (Haemodynamic insufficiency after birth is commonly seen in babies born prematurely. The condition has a significant clinical impact. A final common pathway is seen but ...
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10009196 Circulatory failure neonatal PT
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-002179-12 Sponsor Protocol Number: PRILODE50-FUSION Start Date*: 2022-09-16
    Sponsor Name:Matilde Zaballos
    Full Title: Determination of the effective dose 50 of intrathecal hyperbaric prilocaine required for the transrectal ultrasound guidance fusion-targeted prostate biopsy in ambulatory surgery
    Medical condition: anaesthesia for prostate fusion biopsy in outpatient surgery
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004848 10004825 Biopsy of prostate LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015824-27 Sponsor Protocol Number: MeBN/06/NEB-CBP/001 Start Date*: 2009-12-23
    Sponsor Name:MENARINI Benelux NV/SA
    Full Title: The effects of Nebivolol/HCTZ on Central Arterial Pressure, a randomised double-blind cross-over trial
    Medical condition: Hypertension
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2012-000236-26 Sponsor Protocol Number: CRLX030X2201 Start Date*: 2012-11-06
    Sponsor Name:Novartis Pharma Services AG
    Full Title: An exploratory study to investigate the haemodynamic effects of serelaxin in patients with compensated cirrhosis and portal hypertension
    Medical condition: Compensated alcohol-related cirrhosis and portal hypertension
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004871 10020786 Hypertension portal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-003678-82 Sponsor Protocol Number: CHDR0606 Start Date*: 2007-07-10
    Sponsor Name:Centre for Human Drug Research
    Full Title: Pharmacokinetics and effects of oral clonidine in children with suspected Growth Hormone deficiency
    Medical condition: Clonidine is studied in the paediatric population, more specific children with short stature. It is used as a diagnostic tool to establish Growth Hormone reserve in routine practice.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10005573 Blood growth hormone decreased LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2007-007094-23 Sponsor Protocol Number: Nitrous oxide protocol V5 Start Date*: 2008-10-09
    Sponsor Name:University of Nottingham
    Full Title: Nitrous oxide and cerebral vasodilatation: a dose-response study in healthy volunteers
    Medical condition: The study will be conducted in healthy volunteers. I will evaluate the effects of inhaled concentrations of nitrous oxide, ranging from 0% to 50%, on cerebral blood flow and cerebral vascular tone ...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004012-31 Sponsor Protocol Number: RD 5130-009-07 Start Date*: 2009-07-06
    Sponsor Name:Derby Hospitals NHS Foundation Trust [...]
    1. Derby Hospitals NHS Foundation Trust
    2. The University of Nottingham-Research innovation services
    Full Title: The effects of improving oxygen concentration in the reduction of dialysis induced myocardial stunning – A pilot study
    Medical condition: Chronic renal failure patients who are receiving haemodialysis treatment
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066623 Chronic haemodialysis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-001225-16 Sponsor Protocol Number: 3001077 Start Date*: 2004-10-28
    Sponsor Name:Orion Pharma
    Full Title: Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutami...
    Medical condition: Acutely decompensated heart failure
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2004-004384-29 Sponsor Protocol Number: Levosepsis1 Start Date*: 2005-05-23
    Sponsor Name:Dr GED DEMPSEY, University Hospital Aintree
    Full Title: Double blind randomised controlled trial of Levosimendan versus Dopexamine in septic shock
    Medical condition: Septic Shock
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000174-29 Sponsor Protocol Number: CNS7056-022 Start Date*: 2018-07-25
    Sponsor Name:PAION UK Limited
    Full Title: Phase III confirmatory efficacy and safety trial of remimazolam (CNS7056) compared with propofol for intravenous anaesthesia during elective surgery
    Medical condition: Induction and maintenance of general anaesthesia (GA)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10018061 General anesthesia LLT
    20.0 100000004865 10054434 Induction and maintenance of anesthesia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) BE (Completed) GB (Prematurely Ended) NL (Prematurely Ended) FR (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-000467-23 Sponsor Protocol Number: 1 Start Date*: 2007-08-23
    Sponsor Name:Erasmus MC
    Full Title: Maternal and fetal haemodynamic response to Nifedipine tocolysis in normotensive pregnant women.
    Medical condition: A more detailed investigation of the haemodynamic effect on the mother and fetus of Nifedipine tocolysis . Tocolysis will be used to facilitate external cephalic version for breech presentation at ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10006356 Breech presentation LLT
    9.1 10048773 Tocolysis LLT
    9.1 10013596 Doppler ultrasound LLT
    9.1 10053094 Doppler echocardiography LLT
    Population Age: In utero, Under 18, Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-001430-35 Sponsor Protocol Number: 35RC19_8860_FLUDROSEPSIS Start Date*: 2021-04-21
    Sponsor Name:CHU Rennes
    Full Title: Evaluation of the hemodynamic effects of fludrocortisone on the pressive response to norepinephrine in patients in septic shock
    Medical condition: septic shock
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-003455-36 Sponsor Protocol Number: D3190C00005 Start Date*: 2007-12-21
    Sponsor Name:AstraZeneca AB
    Full Title: A Multi-centre, Double-blind, Randomised, Placebo-controlled, Single-dose, Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness and Haemodynamics of an Intravenous Infusion...
    Medical condition: AZD1305 is a novel antiarrhythmic agent being developed for treatment of atrial fibrillation (AF). Potential indications include conversion of AF to sinus rhythm (SR) and maintenance of SR after c...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended) SE (Prematurely Ended) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-005476-41 Sponsor Protocol Number: MMHSCT1096 Start Date*: 2012-05-18
    Sponsor Name:Manchester Mental Health and Social Care Trust
    Full Title: Ketamine augmentation of ECT to improve outcomes in depression
    Medical condition: Depressive disorder requiring treatment with electroconvulsive treatment (ECT)
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10012378 Depression PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-000140-13 Sponsor Protocol Number: FPCLI001 Start Date*: 2008-05-09
    Sponsor Name:Faron Pharmaceuticals Limited
    Full Title: A Phase I/II Open–Label study to Assess the Safety, Tolerability and Preliminary Efficacy of FP-1201 (Recombinant Human Interferon Beta) in the treatment of patients with Acute Lung Injury and Acut...
    Medical condition: Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-002572-13 Sponsor Protocol Number: RH-4074-OJ1 Start Date*: 2012-09-17
    Sponsor Name:Henrik Kehlet
    Full Title: Efficacy of midodrine for the prevention of orthostatic hypotension during early mobilization after fast-track hip arthroplasty - a randomized, placebo controlled trial
    Medical condition: Postoperative orthostatic hypotension during early mobilization after fast-track hip arthroplasty
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10021100 Hypotension orthostatic LLT
    14.1 10047065 - Vascular disorders 10021102 Hypotension orthostatic symptomatic LLT
    14.1 10022117 - Injury, poisoning and procedural complications 10050632 Postoperative hypotension LLT
    14.1 10047065 - Vascular disorders 10036433 Postural hypotension LLT
    14.1 10047065 - Vascular disorders 10031127 Orthostatic hypotension PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-001121-40 Sponsor Protocol Number: PEA_Bridging_Study Start Date*: 2018-09-17
    Sponsor Name:International CTEPH Association (ICA)
    Full Title: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multicentre, Prospective Study to Assess Efficacy of Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy With High P...
    Medical condition: Chronic Thromboembolic Pulmonary Disease (CTEPH)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10068740 CTEPH LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) FR (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 04 06:21:53 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA